Petros Pharmaceuticals In... (PTPI)
NASDAQ: PTPI
· Real-Time Price · USD
0.03
-0.00 (-10.18%)
At close: Jun 09, 2025, 3:15 PM
Petros Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | 725.4K | 1.58M | 1.42M | 1.39M | -364.25K | 1.67M | 1.99M | 2.52M | 798.1K | -1.46M | 4.19M | 2.47M | -867.16K | 2.15M | 2.46M | 4.08M |
Cost of Revenue | n/a | 264.75K | 287K | 329.11K | 331.83K | 158.15K | 408.48K | 513.86K | 550.74K | 881.33K | 286.52K | 649.22K | 472.34K | 243.73K | 319.16K | 393.29K | 643.39K |
Gross Profit | n/a | 460.65K | 1.29M | 1.09M | 1.06M | -522.4K | 1.27M | 1.48M | 1.97M | -83.23K | -1.74M | 3.54M | 1.99M | -1.11M | 1.83M | 2.06M | 3.43M |
Operating Income | -1.46M | -1.75M | -2.34M | -2.28M | -3.93M | -5.04M | -4.81M | -2.46M | -1.31M | -4.1M | -13.67M | -1.66M | -481.2K | -7.97M | -3.6M | -4.28M | -2.2M |
Interest Income | 47.79K | 24.74K | 75.82K | 119.39K | 151.82K | 227.59K | 168.48K | 52.92K | 66.32K | 14.19K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -1.2M | -9.27M | -2.22M | -662.03K | -2.16M | 318.15K | -4.55M | -2.55M | -1.39M | -4.23M | -13.82M | -1.81M | -174.22K | -8.19M | -1.69M | -2.11M | 3.01M |
Net Income | -2.26M | -9.27M | -2.22M | -662.03K | -8.03M | 318.15K | -4.55M | -2.55M | -219.4M | -4.22M | -13.83M | -1.96M | 3.52M | -8.19M | -1.7M | -2.11M | 3.01M |
Selling & General & Admin | 1.46M | 1.45M | 2.3M | 2.29M | 2.71M | 2.88M | 2M | 2.25M | 2.13M | 2.92M | 2.17M | 3.22M | 3.9M | 4.18M | 3.41M | 4.12M | 3.88M |
Research & Development | n/a | 101.94K | 588.36K | 368.8K | 1.56M | 834.33K | 389.09K | 866.58K | 319.09K | 177.76K | 735.92K | 421.24K | 405.36K | 988.69K | 280.58K | 500.05K | 19.18K |
Other Expenses | n/a | 8.04M | 739.45K | 717.84K | 386.01K | 802.58K | 3.27M | 312.94M | 826.79K | 916.27K | n/a | 1.56M | 1.56M | 1.69M | 1.73M | 1.73M | 1.73M |
Operating Expenses | 1.46M | 1.55M | 3.63M | 3.37M | 4.65M | 4.52M | 5.66M | 3.94M | 3.28M | 4.02M | 4.47M | 5.2M | 5.86M | 6.86M | 5.42M | 6.35M | 5.63M |
Interest Expense | n/a | 167.46K | 158.73K | 114.51K | 120.21K | 125.82K | 131.35K | 136.8K | 142.17K | 144.94K | 147.68K | 150.37K | 153.03K | 11.79K | 67.94K | 115.53K | 173.41K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 9.86M | 3.92M | 3.7M | 4.99M | 4.67M | 6.07M | 4.46M | 3.83M | 4.9M | 4.75M | 5.85M | 6.34M | 7.11M | 5.74M | 6.74M | 6.27M |
Income Tax Expense | 1.06M | 12.47B | n/a | n/a | 5.86M | 125.82K | 866.38K | -83.74M | 218.02M | -10.5K | 10.5K | 150.37K | -3.7M | -9.04K | 2.35K | 6.7K | 173.41K |
Shares Outstanding (Basic) | 1.16M | 80.26M | 4.16M | 1.79M | 1.28M | 151.49K | 1.6M | 2.12M | 2.09M | 2.08M | 2.07M | 2.07M | 2.07M | 1.42M | 982.66K | 960.42K | 975.31K |
Shares Outstanding (Diluted) | 1.16M | 80.26M | 9.83M | 7.39M | 4.76M | 2.38M | 2.12M | 2.12M | 2.09M | 2.08M | 2.07M | 2.07M | 2.07M | 1.42M | 982.66K | 980.23K | 975.47K |
EPS (Basic) | -1.95 | -0.13 | -0.53 | -0.37 | -1.69 | -2.1 | -2.85 | -1.2 | -0.66 | -2.03 | -6.69 | -0.88 | -0.08 | -5.77 | -1.73 | -2.16 | 3.09 |
EPS (Diluted) | -1.95 | -0.13 | -0.53 | -0.37 | -1.69 | -2.1 | -2.85 | -1.2 | -0.66 | -2.03 | -6.69 | -0.88 | -0.08 | -5.78 | -1.73 | -2.2 | 3.09 |
EBITDA | -1.46M | -8.44M | -1.29M | 207.15K | -1.29M | 1.38M | -3.59M | -1.55M | -384.63K | -3.17M | -12.08M | -100.55K | 1.54M | -6.28M | -1.87M | -236.54K | 4.94M |
EBIT | n/a | -9.11M | -2.06M | -547.51K | -2.04M | -5.04M | -4.42M | -2.41M | -1.24M | -4.09M | -13.67M | -1.66M | -21.2K | -8.18M | -1.63M | -1.99M | 3.18M |
Depreciation & Amortization | n/a | 667.29K | 768.26K | 754.67K | 753.53K | 934.79K | 826.79K | 859.33K | 858.35K | 916.27K | 1.56M | 1.59M | 1.59M | 1.69M | 1.76M | 1.75M | 1.75M |